Omicron Variant 2.0

By now you may have heard there’s a newer version of the Omicron variant of Covid-19 that is making its presence felt. The original Omicron variant is known as BA.1 and the new version is called BA.2. Just when you thought we were nearly past the Omicron wave, now comes this new version of itself.

The BA.2 variant of Omicron is under observation by Denmark, India, and the U.K., reports Renee Onque and Denise Roland in The Wall Street Journal. This second variant arose around the same time as the first and comes from the same ancestor strain. According to Theodora Hatziioannou, associate professor of virology at Rockefeller University, the differences between this variant and the BA.1 can be seen in the spike protein of the virus.

This is the first time that two competing variants have emerged in parallel like this, according to Mark Zeller, a genomic epidemiologist at the Scripps Research Institute in San Diego, California. He expected this second variant will drive a rise in cases, but not as much as the original because people who were infected with the original likely have some immunity to BA.2.

The BA.2 variant has been detected in the U.S., according to the CDC. The CDC estimates show that Omicron was likely responsible for 99.9% of Covid-19 infections in the week ending January 22nd. The prevalence of other variants including BA.2 was included in that study. No further data is available yet.

The BA.2 variant has been detected in at least 40 countries including the U.K., Denmark, India, Sweden, Singapore and the Philippines. BA.2 appears to be displacing the BA.1 variant in Denmark. As yet, the World Health Organization has not designated the BA.2 as a “variant of concern.” It isn’t clear yet whether the BA.2 variant behaves any differently than the original Omicron strain. One study at the Serum Institute of Denmark suggested BA.2 may well be over one and a half times more contagious than BA.1. The CDC disputes this conclusion saying, “Currently there is no evidence that the BA.2 lineage is more severe than the BA.1 lineage.”

Those monoclonal antibody treatments originally developed by Regeneron for the Alpha and Delta variants have been less effective with Omicron. However, the monoclonal antibody treatment known as sotrovimab, made by GlaxoSmithKline PLC and Vir Biotechnology, has shown effectiveness against the BA.1 variant and likely will also be effective against BA.2. “We are confident that sotrovimab will continue to provide significant benefit for the early treatment of patients hoping to avoid the most severe consequences of Covid-19,” said George Scangos, chief executive of Vir.

Pfizer and Merck and its partner Ridgeback Biotherapeutics developed antiviral pills for Covid-19 that continue to work against the original Omicron variant and may have similar effects against BA.2. Vaccines are also expected to be just as effective against BA.2 as they are against BA.1.

“I can be pretty confident in saying that vaccines will continue to work really well at keeping people away from the hospital if they are boosted,” said Peter Chin-Hong, infectious disease specialist at the University of California, San Francisco. “When fully vaccinated and boosted, your cells adopt memory and are able to detect similar variants, preventing you from getting extremely sick if infected,” said Dr. Chin-Hong.

Lockdown Catastrophe

 

I’ve written about lockdowns before. In Lockdowns Historically Failed, we discussed the historical record of lockdowns going back to 1918 and the Spanish flu pandemic. In reviewing that history, the World Health Organization (WHO) issued a report in 2006 which concluded “forced isolation and quarantine are ineffective and impractical.” In 2009, a statement was written in a report by medical historian John Barry, that said, “Historical data clearly demonstrate that quarantine does not work unless it is absolutely rigid and complete” – a standard that not even the U.S. military was able to achieve.

More recently, in The Economics of Lockdowns, I reported on the economic analysis from the University of Chicago. Economists Tomas J. Philipson and Casey B. Mulligan said, “Reducing the incidence of disease isn’t necessarily desirable if excessive prevention, in the form of lockdowns or school closures, is more costly to society than the damage done by an illness.”

The rationale for all these lockdowns has always been to contain the spread of the virus and to “save lives.” We have tolerated this new world of lost freedom mostly in the hope that we were indeed saving lives. Indeed, that has been the mantra of our politicians and public-health officials. But what if they were actually wrong? What if all those lockdowns didn’t really save lives?

Now we know the answer to those questions. James Freeman, writing in The Wall Street Journal tells us of a new report from Johns Hopkins economist Steve Hanke, and from other researchers in Denmark and Sweden. They employed a systematic search and screening procedure in which 18,590 studies are identified that could potentially address the belief posed. After three levels of screening, 34 studies ultimately qualified for final analysis. Of these, 24 qualified for inclusion in their meta-analysis.

The study authors said, “This systemic review and meta-analysis are designed to determine whether there is empirical evidence to support the belief that “lockdowns” reduce COVID-19 mortality. Lockdowns are defined as the imposition of at least one compulsory, non-pharmaceutical intervention (NPI).”

The 24 studies were separated into three groups: lockdown stringency index studies, shelter-in place order (SIPO) studies, and specific NPI studies. They report, “An analysis of each of these three groups support the conclusion that lockdowns have had little to no effect on COVID-19 mortality. More specifically, stringency index studies find that lockdowns in Europe and the United States only reduced COVID-19 mortality by 0.2% on average. SIPOs were also ineffective, only reducing COVID-19 mortality by 2.9% on average. Specific NPI studies also find no broad-based evidence of noticeable effects on COVID-19 mortality.

There you have the answer – lockdowns reduced COVID-19 mortality by 0.2% – 2.9% or not at all. Sure, the lives saved in that 0.2% – 2.9% are important, but at what cost? We don’t know the answer in terms of increased deaths due to suicides from mental illness, increased deaths from drug abuse overdoses, increased deaths due to undiagnosed, treatable cancers because people didn’t go for regular screening exams, increased deaths due to uncontrolled diabetes, heart disease and other illnesses. Those are all very real costs of lockdowns.

But we do have some information on the economic costs. A report from WSJ says, “The U.S. national debt exceeded $30 trillion for the first time, reflecting increased federal borrowing during the coronavirus pandemic. Total public debt outstanding was $30.01 trillion as of January 31, according to Treasury Department data released Tuesday. That was a nearly $7 trillion increase from late January 2020, just before the pandemic hit the U.S. economy.”

This should be the last word on the issue of lockdowns. Any politician or public-health official calling for lockdowns in the future must be held accountable. In my business, they would call it malpractice.

Single Payer in California

 

The price of living in California is going up. It is already one of the most expensive states to live in the U.S., ranking third behind Hawaii and the District of Columbia. It has notoriously high housing and transportation costs. But when it comes to state income taxes, California is second to none. With a leading state income tax rate of 13.3%, it rises above even Hawaii.

That’s about to get worse, according to The Wall Street Journal editorial board. Although single-payer healthcare has been relegated to the back burner for now by the White House, the governor of California is anxious to push it through his Democrat-controlled legislature. It passed the Senate in 2017, but collapsed in the more conservative Assembly because it didn’t include funding to pay for its estimated $400 billion annual cost. It also would have required Medicare and Medicaid waivers from the Trump Administration Health and Human Services Department, which was unlikely.

But now progressives are adding gargantuan tax increases to pay for this debacle. Their revived legislation would replace Medicare, Medicaid, and private health insurance with a state-run system and eliminate co-pays, deductibles, and premiums. Californians would also be entitled to an expansive list of benefits including vision, dental, hearing, and long-term care. That ought to swell the ranks of the illegal immigrants crossing the southern border.

If this sounds too good to be true, that’s because it is. Like all socialized medicine systems, a board of bureaucrats would be responsible for controlling costs. (They called this the Independent Payment Advisory Board (IPAB) in the original ObamaCare legislation.) WSJ says, “The simple truth is their job is to ration care. Deliberations about rationing decisions would be concealed from the public. The legislation “imposes a limitation on the public’s right of access to the meetings of public bodies” in order to “protect private, confidential, and proprietary information.” While Californians would technically be entitled to a “free” knee replacement, they might not get one if bureaucrats consider them too old – but the state won’t let people know that’s the reason.”

The bill would also effectively ban private insurance for benefits covered by the state – basically everything besides cosmetic surgery – which most insurance doesn’t cover anyway. This could lead to medical tourism in nearby states such as Arizona.

The state would still need those waivers from the White House for HHS, but this is unlikely to be a problem with the current administration. Progressives have been pushing for such changes to our national healthcare system since Vermont Senator Bernie Sanders introduced similar legislation called Medicare for All. Furthermore, the current HHS Secretary is none other than Xavier Becerra, former Congressman from California, who has supported single-payer healthcare in Congress.

How much would taxes increase?

WSJ says they start with a 2.3% excise tax on business with more than $2 million in gross receipts for what the legislation calls “the privilege of doing business in this state.” This gross receipts tax, which would apply to revenues rather than profits, would punish low-margin businesses large and small. Many will take their privilege elsewhere. (Just another reason for Californians to leave the state as has been happening frequently. In a recent post, The Blue States Exodus, I reported that California leads the nation in emigration of its residents.)

Employers with 50 or more workers would also pay a 1.25% payroll tax, (on top of current payroll taxes) which would be passed onto workers. Workers earning more than $49,900 would pay an additional 1% payroll tax. These taxes would raise the effective income tax on wage earners making more than $61,213 to 11.55%, more than millionaires pay in every state except New York.

An additional progressive surtax would start at 0.5% on income over $149,509 and rise to 2.5% at $2,484,121. Couples making more than $299,509 would pay a top rate of 12.55%. The top marginal rate would rise to 15.8% on unearned income, including capital gains, and 18.05% on wage income.

If you think you can escape these taxes by spending most of your time in another state, think again. This surtax would apply “as if the resident were a resident of this state for the entire taxable year,” which suggests that part-time residents would be soaked even if they spend most of the year in Florida or Texas. Reminds one of Hotel California – where you can always check in but never check out.

Not to be undone by the California constitution, which requires two-thirds of the Legislature to raise taxes, the bill says a simple majority may raise tax rates if necessary to fund single-payer. WSJ says Democrats have a comfortable super-majority holding 75% of seats in the state Assembly and 78% in the state Senate. With these strong numbers, it is likely Governor Gavin Newsome will have his way. However, the tax increases would still have to be approved by voters since they would override the state constitutional’s spending limit. This should be a good test of the strength of the progressives in the state. It is clear they won’t rest until they have put the government in charge of your healthcare.

 

Note: For more on single payer healthcare, go to the “Search my Posts” box on the left of the screen and put in words like “Single Payer” and “Medicare for All.”

Author’s Addendum:

On the same day this post was published, The Wall Street Journal reported the California bill, proposed by Progressive California Assemblyman Ash Kalra of San Jose, was killed in committee. Kalra said, “I don’t believe it would have served the cause of getting single payer done by having the vote and having it go down in flames and further alienating members.”

The editors of WSJ said, “These sweeping tax increases were too politically toxic even for Democrats who believe confiscatory taxation as an article of faith. Governor Gavin Newsom campaigned on single-payer but declined to endorse the bill. “It’s one thing to say, it’s another to do,” he said last month. Lest anyone think single-payer is dead, Mr. Kalra said “this is only a pause” and “we will not give up.” The left never does.”